Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialBert H. O’Neil, Richard M. Goldberg, Howard S. Höchster et al.|UNC Libraries|2020Cited by 96